Coreceptor/chemokine receptor expression on human hematopoietic cells: Biological implications for human immunodeficiency virus-type 1 infection

Blood

Volumn 93, Issue 4, 1999, Pages 1145-1156

  Lee, Benhur ^a   Ratajczak, Janina ^a   Doms, Robert W ^a   Gewirtz, Alan M ^a   Ratajczak, Mariusz Z ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; GAMMA INTERFERON;

AIDS RELATED COMPLEX; ARTICLE; BURST FORMING UNIT E; CELL LINEAGE; COLONY FORMING UNIT GM; CYTOPENIA; FLUORESCENCE ACTIVATED CELL SORTER; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LYMPHOCYTE HOMING; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033557575     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.4.1145     Document Type: Article

References (53)

1. Aboulafia DM, Mitsuyasu RT: Hematologic abnormalities in AIDS. Hematol Oncol Clin North Am 5:195, 1991
2. Davis BR, Zauli G: Effect of human immunodeficiency virus infection on haematopoiesis. Clin Haematol 8:113, 1995
3. Lee B, Doranz BJ, Ratajczak MZ, Doms RW: An intricate web: Chemokine receptors, HIV-1 and hematopoiesis. Stem Cells 16:79, 1998
4. Moore JP, Trkola A, Dragic T: Coreceptors for HIV-1 entry. Curr Opin Immunol 9:551, 1997
5. Doms RW, Peiper SC: Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology 235:179, 1997
6. McNicholl JM, Smith DK, S.H.Qari, Hodge T: Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (D32CCR5). Emerg Infect Dis 3:261, 1997
7. Weissman D, Rabin RL, Arthos J, Rubbert A, Dybul M, Swofford R, Venkatesan S, Farber JM, Fauci AS: Macropahge-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389:981, 1997
8. Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, Siani MA, Thompson DA, Schlessinger J, Littman DR: Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 186:1793, 1997
9. Zauli G, Vitale M, Gibellini D, Capitani S: Inhibition of purified Cd34+ hematopoietic progenitor cells by human immunodeficiency virus type 1 or gp120 mediated by endogenous transforming growth factor β1. J Exp Med 183:99, 1996
10. Zauli G, Re MC, Furlini G, Giovannini M, LaPlaca M: Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human hematopoietic progenitors (CD34+ cells). J Gen Virol 73:417, 1992
11. Maciejewski JP, Weichold FF, Young NS: HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-α. J Immunol 53:4303, 1994
12. Carr JM, Ramshaw HS, Li P, Burnell CJ: CD34+ cells and their derivatives contain mRNA for CD4 and human immunodeficiency virus (HIV) coreceptors and are susceptible to infection with M- and T-tropic HIV. J Gen Virol 79:71, 1998
13. + hematopoietic progenitor cells. Blood 89:3522, 1997
14. Moses A, Nelson J, Bagby GC: The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91:1479, 1998
15. Cohen OJ, Kinter A, Fauci AS: Host factors in the pathogenesis of HIV disease. Immunol Rev 159:31, 1997
16. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature 384:529, 1996
17. Aiuti A, Webb IJ, Bleul C, Springer T, Guitierrez Ramos JC: The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood. J Exp Med 185:111, 1997
18. + marrow cells. Blood 86:2161, 1995
19. Ratajczak MZ, Pletcher CH, Marlicz, W, Machalinski B, Moore J, Wasik M, Ratajczak J, Gewirtz A: CD34+, kit+, rhodamine123low phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Leukemia 12:942, 1998
20. Ratajczak J, Marlicz W, Keidel A, Machalinski B, Ratajczak MZ, Gewirtz AM: Effect of interleukin-1α and interleukin-1β on erythroid progenitor cell growth in serum free cultures: An in vitro study relevant to the pathogenesis of the anemia of chronic disease. Hematology 2:21, 1997
21. Ratajczak J, Marlicz W, Machalinski B, Pertusini E, Czajka R, Ratajczak MZ: An improved serum free system for cloning human "pure" erythroid colonies. The role of different growth factors and cytokines on BFU-E formation by the bone marrow and cord blood CD34+ cells. Folia Histochem Cytobiol 36:55, 1998
22. Ratajczak J, Machalinski B, Samuel A, Pertusini E, Majka M, Czajka R, Ratajczak MZ: A novel serum free system for cloning human megakaryocytic progenitors (CFU-Meg). The role of thrombopoietin and other cytokines on bone marrow and cord blood CFU-Meg growth under serum free conditions. Folia Histochem Cytobiol 36:61, 1998
23. Ratajczak MZ, Ratajczak J, Marlicz M, Pletcher CH, Machalinski B, Moore J, Hung H-L, Gewirtz AM: Recombinant human thrombopoietin (TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis. Br J Haematol 98:8, 1997
24. Zauli G, Furlini G, Vitale M, Re CM, Gibellini D, Zamia L, Visani G, Borgatti P, Captani S, LaPLaca M: A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type I. Blood 84:1896, 1994
25. Connor RI, Chen BK, Choe S, Landau NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935, 1995
26. Chen BK, Saksela K, Andino R, Baltimore D: Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J Virol 68:654, 1994
27. Mackay CR: What chemokine is that? Curr Biol 7:R384, 1997
28. Rollins BJ: Chemokines. Blood 90:909, 1997
29. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635, 1996
30. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 185:621, 1997
31. Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP: Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J Virol 72:396, 1998
32. McKnight A, Wilkinson D, Simmons G, Talbot S, Picard L, Ahuja M, Marsh M, Hoxie JA, Clapham PR: Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 71:1692, 1997
33. Broxmeyer HE, Cooper S, Hague N, Benninger L, Sarris A, Cornetta K, Vadhan-Raj S, Hendrie P, Mantel C: Human chemokines: Enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann Hematol 71:235, 1995
34. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB: Identification and characterization of an inhibitor of haematopoietic stem cell proliferation. Nature 344:442, 1990
35. Berger EA, Doms RW, Fenyo E-M, Korber BTM, Littman DR, Moore JP, Sattentau QJ, Schuitemaker H, Sodroski J, Weiss RA: A new classification for HIV-1. Nature 391:240, 1998
36. Chelucci C, Fedrico M, Guerriero R, Mattia G, Casella I, Pelosi E, Testa U, Mariani G, Hassan HJ, Peschle C: Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 91:1225, 1998
37. Yi Y, Rana S, Turner JD, Gaddis N, Collman RG: CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 72:772, 1998
38. Rana S, Besson G, Cook DG, Rucker J, Smyth RJ, Yi Y, Turner J, Guo H, Du J-G, Peiper SC, Lavi E, Samson M, Libert F, Liesnard C, Vassart G, Doms RW, Parmentier M, Collman RG: Role of CCR5 in infection of primary macrophages and lymphocytes by M-tropic strains of HIV: Resistance to patient-derived and prototype isolates resulting from the Δccr5 mutation. J Virol 71:3219, 1997
39. Platt EJ, Wehrly K, Kuhnman SE, Kabat D: Effects of CCR5 and CD4 cell surface concentrations for infections by primary and laboratory-adapted isolates of human immunodeficiency virus type I. J Virol 72:2855, 1998
40. Kozak SL, Platt EJ, Madani N, Ferro FE, Peden K, Kabat D: CD4, CXCR4, and CCR5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type I. J Virol 71:873, 1997
41. Chackerian B, Long EM, Luciw PA, Overbaugh O: Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 71:3932, 1997
42. Jenkins M, Hanley MB, Moreno MB, Wieder E, McCune JM: Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood 91:2672, 1998
43. Marandin A, Katz A, Oksenhendler E, Tulliez M, Picard F, Vainchenker W, Louache F: Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 88:4568, 1996
44. Dumonceaux J, Nicole S, Chanel C, Quivet L, Amara A, Briand P, Hazan U: Spontaneous mutation in the Env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 72:512, 1998
45. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, Wells TNC, Power CA, Sutterwala SS, Doms RW, Landau NR, Hoxie JA: CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745, 1996
46. Reeves JD, McKnight A, Potempa S, Simmons G, Gray PW, Power CA, Wells T, Weiss RA, Talbot SJ: CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4. CCR-3, and V28 for entry. Virology 231:130, 1997
47. Su S, Mukaida N, Wang J, Zhang Y, Takami A, Nakao S, Matsushima K: Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1-alpha by interacting mainly with CC chemokine receptor. CCR1. Blood 90:605, 1997
48. Schmidtmayerova H, Nottet HSL, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B: Human immunodeficiency virus type I infection alters chemokine beta peptide expression in human moncytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 93:700, 1996
49. Saha K, Bentsman G, Chess L, Volsky DJ: Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type I (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 72:876, 1998
50. Mackewicz CE, Barker E, Greco G, Reyes-Teran G, Levy JA: Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest 100:921, 1997
51. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sekaly RP, Fauci AS: Lack of evidence for a dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265:248, 1994
52. Sozzani S, Ghezzi S, Iannolo G, Luini W, Borsatti A, Polentarutti N, Sica A, Locati M, Mackay C, Wells TNC, Biswas P, Vicenzi E, Poli G, Mantovani A: IL-10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187:439, 1998
53. Di Marzio P, Tse J, Landau NR: Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Human Retroviruses 14:129, 1998